METHOD VALIDATION OF CAPECITABINE IN API AND PHARMACEUTICAL DOSAGE FROM BY UV SPECTROPHOTOMETRIC METHOD
DOI:
https://doi.org/10.22159/ajpcr.2020.v13i5.36985Keywords:
Capecitabine, UV spectrophotometric method, Method validationAbstract
Objective: The simple, rapid spectrophotometric method was developed for the determination of capecitabine, an anticancer drug, in pharmaceutical formulations. Among the approaches, most commonly used targeted mechanism is pH-dependent delivery system which is based on pH gradient of the gastrointestinal tract (GIT) that increases progressively from the stomach.
Methods: The focus of the present study is to similarize the capecitabine drug in bulk form with the marketed tablet (Capegard 500) on the simple, accurate, and precise manner by UV spectrophotometer.
Results: Beer’s law was obeyed over a concentration range of 5–30 μg/mL in HCl at pH 1.2 and in phosphate buffer at pH 6.8 and 7.4. The linear regression equations of pure drug were found to be y = 0.0135x+0.2014, y = 0.0147x+0.2153, and y = 0. 0245x+0.1507 in HCl, phosphate buffer at 6.8 and 7.4, respectively, whereas the linear regression equations of marketed tablet were found to be y = 0.0158x+0.1964, y = 0.0192x+0.2261, and y = 0.015x+0.2032, respectively, and the three methods were validated as per the International Council for Harmonisation guideline (ICH).
Conclusion: The regression values of every equation were found to be above 0.990 which indicated that all the equations were maintaining linearity.
Downloads
References
Merck.: The Merck Index. Merck Research Laboratories., 13th ed.: USA: Merck and Co. Inc.; USA: 2001.
Bhatia MS, Raut JN, Barve AC, Patil PS, Jadhav SD. HPLC assay method development and validation for quantification of capecitabine in tablets and forced degradation samples. Marmara Pharm J 2017;21:660-8.
Dooley M, Goa KL. Capecitabine. Vol. 58. Berlin: Springer; 1999. p. 69-76.
Sharma N, Harikumar SL. Polymers for colon targeted delivery: A review. Int J Drug Dev Res 2013;5:21-31.
Amidon A, Brown JE, Dave VS. Colon targeted oral drug delivery systems: Design trends and approaches. AAPS PharmSciTech 2015;16:731-41.
Available from: https://www.pharmaguideline.com/2010/09/preparation-of-buffer-solutions.html. [Last accessed on 2019 Sep 02].
Mondal S, Narendra R, Ghosh D, Ganapaty S. Development and validation of RP-HPLC and UV spectrophotometric methods for the quantification of capacitabine. Int J Pharm Pharm Sci 2016;5:279-87.
Kumbhar SC, Salunkhe VR. UV spectrophotometric method development for capecitabine in eudragit and chitosan based microspheres and its validation. Ind J Pharm Bio Res 2013;1:32-8.
Sereya K, Latha ST, Kamalakannan D, Jambulingam M. A new UV spectrophotometric method development and validation for erlotinib by derivative spectroscopy. Int J Pharm H Care Res 2013;1:23-7.
Gadiya H, Maheshwari M, Dashora A. UV analytical method development and validation for simultaneous estimation of dapoxetine hydrochloride and sildenafil citrate in tablet dosage form. Asian J Pharm Clin Res 2019;1:328-31.
Sawsan A, Razeq A, Demerdash AO, Sanabary FE. HPLC, densitometric and visible- spectrophotometric determination of triclabendazole and ivermectin. Int J Pharm Res 2016;13:1-14.
Saravanan VS, Rao BM. Analytical method development and validation for the determination of erlotinib hydrochloride bulk and in pharmaceutical dosage form. J Drug Deliv Ther 2013;3:50-4.
Limbani RK, Jignasa M, Pashat Y. Simultaneous equation method for the estimation of ivermectin and clorsulon in their combined pharmaceutical dosage form by UV-visible spectrophotometry. Int Bulletin Drug Res 2014;4:131-9.
Pallavi K, Srinivasa BP, Kishore BG. Development and validation of UV spectrophotometric method and RP-HPLC method for estimation of capecitabine in bulk and tablet dosage forms. Int J Appl Pharm 2016;8:24-9.
Basha SS, Manikanta S, Jahnavi T. UV Spectrophotometric determination of rupatadine fumarate in bulk and tablet dosage form by using single point standardization method. Int J Pharm Pharm Sci 2019;7:120-4.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.